Back to GetFilings.com




QuickLinks -- Click here to rapidly navigate through this document

U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-Q

(Mark One)


ý

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2002

o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE TRANSITION PERIOD FROM                              TO                             

Commission file number 000-33357

BRUKER AXS INC.
(Exact name of registrant as specified in its charter)

Delaware
(State or other jurisdiction of
incorporation or organization)
  39-1908020
(IRS Employer
Identification Number)

5465 East Cheryl Parkway
Madison, WI 53711

(Address of principal executive offices)

(608) 276-3000
(Registrant's telephone number, including area code)

        Check whether the registrant: (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

(1) Yes ý        No o

        As of August 1, 2002 there were 56,180,338 shares of the Registrant's common stock outstanding.




 
   
  PAGE
NUMBER

PART I   FINANCIAL INFORMATION    

ITEM 1:

 

Financial Statements

 

 
    Condensed Consolidated Balance Sheets as of June 30, 2002 and December 31, 2001   3
    Condensed Consolidated Statements of Operations for the three and six months ended June 30, 2002 and 2001   4
    Condensed Consolidated Statements of Cash Flows for the six months ended June 30, 2002 and 2001   5
    Notes to Condensed Consolidated Financial Statements   6

ITEM 2:

 

Management's Discussion and Analysis of Financial Condition and Results of Operations

 

14

ITEM 3:

 

Quantitative and Qualitative Disclosures about Market Risk

 

19

PART II

 

OTHER INFORMATION

 

 

ITEM 1:

 

Legal Proceedings

 

22

ITEM 2:

 

Changes in Securities and Use of Proceeds

 

22

ITEM 3:

 

Defaults Upon Senior Securities

 

22

ITEM 4:

 

Submission of Matters to a Vote of Security Holders

 

22

ITEM 5:

 

Other Information

 

23

ITEM 6:

 

Exhibits and Reports on Form 8-K

 

23

 

 

SIGNATURES

 

24

PART I. FINANCIAL INFORMATION

ITEM 1. Financial Statements


Bruker AXS Inc.

Condensed Consolidated Balance Sheets

 
  June 30,
2002

  December 31,
2001

 
 
  (Unaudited)

 
ASSETS              
Current assets:              
  Cash and cash equivalents   $ 50,672,561   $ 48,787,026  
  Accounts receivable, net     21,198,530     17,206,783  
  Inventories     34,532,499     26,768,962  
  Prepaid expenses     1,677,448     809,303  
  Other assets     1,391,016     951,625  
  Deferred income taxes     1,036,796     886,365  
   
 
 
    Total current assets     110,508,850     95,410,064  
Property and equipment, net     18,300,233     8,150,910  
Restricted cash     121,169     108,074  
Other     334,865     1,053,620  
Intangible assets—trademarks and tradenames, net     250,250     250,250  
Goodwill, net     4,077,111     3,099,314  
Investments in other companies     2,000,000     2,000,000  
Deferred income taxes     2,186,511     2,018,314  
   
 
 
    Total assets   $ 137,778,989   $ 112,090,546  
   
 
 
LIABILITIES AND SHAREHOLDERS' EQUITY              
Current liabilities:              
  Short-term borrowings   $ 1,956,765   $ 241,957  
  Current portion of long-term debt     573,549      
  Related party debt—current     253,036     229,180  
  Accounts payable     9,095,646     7,415,956  
  Other current liabilities     24,940,213     20,995,538  
   
 
 
    Total current liabilities     36,819,209     28,882,631  
   
 
 
Long-term debt     9,055,037     2,200,000  
Accrued pension     4,250,594     3,437,058  
Minority interest in consolidated subsidiary     19,599      
Shareholders' equity:              
  Preferred stock, $.01 par value, 5,000,000 authorized, 0 shares issued and outstanding at June 30, 2002 and December 31, 2001          
  Common stock, $.01 par value, 100,000,000 shares authorized, 56,180,338 and 54,830,338 shares issued and outstanding at June 30, 2002 and December 31, 2001, respectively     561,804     548,304  
  Additional paid-in capital     87,118,989     79,135,021  
  Accumulated deficit     (656,371 )   (1,574,502 )
  Accumulated other comprehensive income (loss)     610,128     (537,966 )
   
 
 
    Total shareholders' equity     87,634,550     77,570,857  
   
 
 
    Total liabilities and shareholders' equity   $ 137,778,989   $ 112,090,546  
   
 
 

The accompanying notes are an integral part of these financial statements.

3



Bruker AXS Inc.

Condensed Consolidated Statements of Operations

 
  Three Months Ended
June 30,

  Six Months Ended
June 30,

 
 
  2002
  2001
  2002
  2001
 
 
  (Unaudited)

  (Unaudited)

 
Net sales   $ 24,034,862   $ 20,208,053   $ 47,830,423   $ 39,053,537  

Cost of sales

 

 

14,659,919

 

 

12,449,269

 

 

29,337,536

 

 

24,162,383

 
   
 
 
 
 
 
Gross profit

 

 

9,374,943

 

 

7,758,784

 

 

18,492,887

 

 

14,891,154

 
   
 
 
 
 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 
  Research and development     2,801,804     1,913,458     4,915,003     3,582,544  
  In-process research and development         3,590,000         3,590,000  
  General and administrative     2,013,585     1,293,824     3,611,698     2,262,758  
  Marketing and selling     5,058,168     4,251,301     9,726,321     7,967,235  
   
 
 
 
 
  Total operating expenses     9,873,557     11,048,583     18,253,022     17,402,537  
   
 
 
 
 

Operating (loss) income

 

 

(498,614

)

 

(3,289,799

)

 

239,865

 

 

(2,511,383

)

Other expense (income):

 

 

 

 

 

 

 

 

 

 

 

 

 
  Interest income     (181,060 )   (126,089 )   (414,341 )   (286,729 )
  Interest expense—third party     61,175     106,736     121,696     160,188  
  Interest expense—related party     1,056     79,794     2,047     153,565  
  Other (income) expense     (1,391,318 )   (245,321 )   (984,598 )   20,541  
   
 
 
 
 

Income (loss) before income taxes and minority interest in subsidiary loss

 

 

1,011,533

 

 

(3,104,919

)

 

1,515,061

 

 

(2,558,948

)

Income tax expense (benefit)

 

 

403,597

 

 

(1,267,929

)

 

598,438

 

 

(986,397

)
   
 
 
 
 
Income (loss) before minority interest in subsidiary loss     607,936     (1,836,990 )   916,623     (1,572,551 )

Minority interest in subsidiary loss

 

 

648

 

 


 

 

1,508

 

 


 
   
 
 
 
 
 
Net income (loss)

 

 

608,584

 

 

(1,836,990

)

 

918,131

 

 

(1,572,551

)

Preferred stock dividend

 

 


 

 

(369,862

)

 


 

 


 
Preferred stock accretion         166,881         166,881  
   
 
 
 
 

Net income (loss) available to common shareholders

 

$

608,584

 

$

(1,634,009

)

$

918,131

 

$

(1,739,432

)
   
 
 
 
 

Earnings (loss) per share:

 

 

 

 

 

 

 

 

 

 

 

 

 
  Basic   $ 0.01   $ (0.04 ) $ 0.02   $ (0.04 )
  Diluted   $ 0.01   $ (0.04 ) $ 0.02   $ (0.04 )

The accompanying notes are an integral part of these financial statements.

4



Bruker AXS Inc.

Condensed Consolidated Statements of Cash Flows

 
  Six Months Ended
June 30,

 
 
  2002
  2001
 
 
  (Unaudited)

 
Cash flows from operating activities:              
  Net income (loss)   $ 918,131   $ (1,572,551 )
  Adjustments to reconcile net income (loss) to cash flows used in operating activities:              
    Depreciation and amortization     1,506,294     1,380,541  
    Deferred income taxes     (392,930 )   (1,554,933 )
    Provision for doubtful accounts     220,533     (52,410 )
    Stock compensation     (138,612 )   89,565  
    Write-off of acquired in-process research and development         3,590,000  
    Minority interest in consolidated subsidiary     (1,508 )    
  Changes in operating assets and liabilities:              
    Accounts receivable     (2,522,615 )   (3,115,018 )
    Inventories     (3,488,022 )   (2,417,536 )
    Other assets and prepaid expenses     (576,820 )   (299,359 )
    Accounts payable     922,143     2,243,230  
    Accrued pension     404,494     355,022  
    Other current liabilities     (900,749 )   133,917  
   
 
 
Net cash used in operating activities     (4,049,661 )   (1,219,532 )
   
 
 
Cash flows from investing activities:              
  Purchase of property and equipment     (9,838,183 )   (1,001,492 )
  Cash contribution from minority shareholders     21,107      
  Acquisition of MAC Science Ltd.     (274,101 )    
  Acquisition of Nonius Group, net of cash acquired         (6,235,547 )
  Investment in other companies         (500,000 )
   
 
 
Net cash used in investing activities     (10,091,177 )   (7,737,039 )
   
 
 
Cash flows from financing activities:              
  Proceeds from/(repayment of) line of credit     1,554,468     (5,307,125 )
  Repayment of related party debt         (1,043,584 )
  Issuance of long-term debt     6,882,507      
  Proceeds from issuance of common stock, net of issuance costs     8,136,081      
  Proceeds from issuance of preferred stock, net of issuance costs         22,273,136  
   
 
 
Net cash provided by financing activities     16,573,056     15,922,427  
   
 
 
  Effect of exchange rate changes on cash     (546,683 )   (167,596 )
   
 
 
Net increase in cash and cash equivalents     1,885,535     6,798,260  
Cash and cash equivalents at beginning of period     48,787,026     2,460,457  
   
 
 
Cash and cash equivalents at end of period   $ 50,672,561   $ 9,258,717  
   
 
 

The accompanying notes are an integral part of these financial statements.

5



Bruker AXS Inc.

Notes to Condensed Consolidated Financial Statements

1. Description of Business and Basis of Presentation

        Bruker AXS Inc. (the "Company") designs, manufactures, distributes and services systems and provides complete solutions in X-ray instrumentation used in non-destructive molecular and elemental analysis in academic, research and industrial applications.

        The financial statements represent the consolidated accounts of Bruker AXS Inc. and its wholly- and majority-owned subsidiaries. All significant intercompany transactions and balances have been eliminated.

        The condensed consolidated financial statements as of June 30, 2002 and for the three and six months ended June 30, 2002 and 2001 have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three and six months ended June 30, 2002 are not necessarily indicative of the results that may be expected for the year ending December 31, 2002. The balance sheet data as of December 31, 2001 has been derived from the audited financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America.

        Although management believes that the disclosures are adequate to make the information presented not misleading, it is suggested that these condensed consolidated financial statements be read in conjunction with the consolidated financial statements and notes thereto included in the Company's Annual Report on Form 10-K for the year ended December 31, 2001, as filed with the Securities and Exchange Commission.

2. Summary of Significant Accounting Policies

        The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

        Minority interest in consolidated subsidiary represents the minority common shareholders' proportionate share of the equity of Incoatec GmbH, a German entity. Incoatec GmbH has been a consolidated subsidiary since February 2002 when the Company contributed $21,968 of cash to this entity. The Company also guarantees approximately $165,000 of Incoatec GmbH's debt. As of June 30, 2002, the Company owned 51% of Incoatec GmbH.

        Certain direct development costs associated with internal-use software are capitalized, including external direct costs of material and services and payroll costs for employees devoting time to the software projects. These costs are included within property and equipment and are amortized on a

6


straight-line basis over a three- to five- year period beginning when the asset is substantially ready for use. Costs incurred during the preliminary project stage, as well as maintenance and training costs, are expensed when incurred.

        In June 2001, the Financial Accounting Standards Board ("FASB") issued Statement of Financial Accounting Standards ("SFAS") No. 143, "Accounting for Asset Retirement Obligations." SFAS No. 143 requires entities to record the fair value of a liability for an asset retirement obligation in the period in which it is incurred. When the liability is initially recorded, the entity capitalizes a cost by increasing the carrying amount of the related long-lived asset. Over time, the liability is accreted to its present value each period, and the capitalized cost is depreciated over the useful life of the related asset. Upon settlement of the liability, an entity either settles the obligation for its recorded amount or incurs a gain or loss upon settlement. The standard is effective for fiscal years beginning after June 15, 2002. The Company believes SFAS No. 143 will not have a material effect on the results of operations or financial position.

        In August 2001, the FASB issued SFAS No. 144, "Accounting for the Impairment or Disposal of Long-Lived Assets." SFAS No. 144 addresses financial accounting and reporting for the impairment or disposal of long-lived assets. The accounting model for long-lived assets to be disposed of by sale applies to all long-lived assets, including discontinued operations. SFAS No. 144 requires that those long-lived assets be measured at the lower of carrying amount or fair value less cost to sell, whether reported in continuing operations or in discontinued operations. Therefore, discontinued operations will no longer be measured at net realizable value or include amounts for operating losses that have not yet occurred. SFAS No. 144 also broadens the reporting of discontinued operations to include all components of an entity with operations that can be distinguished from the rest of the entity and that will be eliminated from the ongoing operations of the entity in a disposal transaction. The provisions of this statement are effective for financial statements issued for fiscal years beginning after December 15, 2001, and interim periods within those fiscal years, with early application encouraged. The Company adopted this statement on January 1, 2002. SFAS No. 144 did not have a material effect on the results of operations or financial position.

        In April 2002, the FASB issued SFAS No. 145, "Rescission of FASB Statements No. 4, 44, and 64, Amendment of FASB No. 13, and Technical Corrections." This statement requires that gains or losses from extinguishments of debt should be classified as extraordinary items only if they meet the criteria in Accounting Principles Board Opinion No. 30, "Reporting the Results of Operations—Reporting the Effects of Disposal of a Segment of a Business, and Extraordinary, Unusual and Infrequently Occurring Events and Transactions." SFAS No. 145 rescinds SFAS No. 64, "Extinguishments of Debt Made to Satisfy Sinking-Fund Requirements" and SFAS No. 4, "Reporting Gains and Losses from Extinguishment of Debt." This statement also amends SFAS No. 13, "Accounting for Leases" to require sale-leaseback accounting for certain lease modifications that have economic effects that are similar to sale-leaseback transactions. SFAS No. 145 also rescinds SFAS No. 44, "Accounting for Intangible Assets of Motor Carriers." This statement also makes various technical corrections to existing pronouncements which are not substantive in nature. The provisions of this statement related to the rescission of SFAS No. 4 shall be applied in fiscal years beginning after May 15, 2002, with early application encouraged. The provisions of this statement related to SFAS No. 13 shall be effective for transactions occurring after May 15, 2002, with early application encouraged. All other provisions of this statement shall be

7



effective for financial statements issued on or after May 15, 2002, with early application encouraged. The Company believes SFAS No. 145 will not have a material effect on the results of operations or financial position.

        In June 2002, the FASB issued SFAS No. 146, "Accounting for the Costs Associated with Exit or Disposal Activities." SFAS No. 146 requires companies to recognize costs associated with exit or disposal activities when they are incurred rather than at the date of a commitment to an exit plan or disposal plan. This statement replaces Emerging Issues Task Force Issue No. 94-3, "Liability Recognition for Certain Employee Termination Benefits and Other Costs to Exit an Activity (including Certain Costs Incurred in a Restructuring)." The provisions of this statement are to be applied prospectively to exit or disposal activities initiated after December 31, 2002, with early application encouraged.

3. Income Taxes

        The income tax provision is determined by applying an estimated annual effective income tax rate to income before income taxes. The estimated annual effective income tax rate is based on the most recent annualized forecast of pretax income, permanent book/tax differences and tax credits.

4. Inventories

        Inventories were comprised of the following:

 
  June 30,
2002

  December 31,
2001

Raw materials   $ 12,307,121   $ 9,783,562
Work-in-process     8,660,358     6,262,864
Finished goods     10,742,851     7,483,259
Service parts     2,822,169     3,239,277
   
 
Total inventories   $ 34,532,499   $ 26,768,962
   
 

5. Goodwill and Other Intangible Assets

        The Company adopted SFAS No. 142, "Goodwill and Other Intangible Assets," in the first quarter of fiscal 2002. SFAS No. 142 required that goodwill and intangible assets with indefinite useful lives not be amortized. Instead, in accordance with the provisions of SFAS No. 142, these assets will be tested for impairment annually, or on an interim basis when events or changes in circumstances warrant. Under the transitional provisions of SFAS No. 142, the Company tested goodwill and intangible assets with indefinite useful lives for impairment as of January 1, 2002 pursuant to the method prescribed by SFAS No. 142. Based on the first step of the impairment test, it is anticipated that an impairment loss for goodwill may be recorded in 2002; however, the Company is unable at this time to estimate the effect of this potential loss on earnings or financial position. Any impairment loss will be recorded as a cumulative effect of change in accounting principle on the consolidated statement of operations in accordance with the transitional provisions of SFAS No. 142.

        Application of the non-amortization provisions of SFAS No. 142 will reduce amortization expense by approximately $165,000 in fiscal 2002. The following sets forth a reconciliation of net income (loss)

8



for the three and six months ended June 30, 2002 and 2001 adjusted for the non-amortization provisions of SFAS No. 142.

 
  Three Months Ended
June 30,

  Six Months Ended
June 30,

 
 
  2002
  2001
  2002
  2001
 
Reported net income (loss)   $ 608,584   $ (1,836,990 ) $ 918,131   $ (1,572,551 )
Add back: goodwill amortization, net of tax         22,445         22,445  
Add back: trademarks and tradenames amortization, net of tax         1,918         1,918  
   
 
 
 
 
Adjusted net income (loss)   $ 608,584   $ (1,812,627 ) $ 918,131   $ (1,548,188 )
   
 
 
 
 

        The non-amortization provisions of SFAS No. 142 had no impact on basic and diluted earnings (loss) per share for the three and six months ended June 30, 2002 and 2001.

6. Other (Income) Expense

        Other (income) expense was comprised of the following:

 
  Three Months Ended
June 30,

  Six Months Ended
June 30,

 
 
  2002
  2001
  2002
  2001
 
Exchange (gains) losses on foreign currency transactions   $ (1,529,493 ) $ (104,112 ) $ (1,305,926 ) $ 110,735  
Depreciation (appreciation) of the fair value of derivative financial instruments     138,175     (141,209 )   321,328     (90,194 )
   
 
 
 
 
Total other (income) expense   $ (1,391,318 ) $ (245,321 ) $ (984,598 ) $ 20,541  
   
 
 
 
 

7. Earnings (Loss) Per Share

        Basic earnings (loss) per share is computed by dividing net income (loss) available to common shareholders by the weighted average number of common shares outstanding for the period. Diluted earnings (loss) per share is computed by dividing net income (loss) by the weighted average number of common shares and, if applicable, common stock equivalents which would arise from the exercise of

9



stock options and conversion of preferred shares. The following table reconciles the numerators and denominators used to calculate basic and diluted earnings (loss) per share:

 
  Three Months Ended
June 30,

  Six Months Ended
June 30,

 
 
  2002
  2001
  2002
  2001
 
Income available to common shareholders:                          
  Net income (loss)   $ 608,584   $ (1,836,990 ) $ 918,131   $ (1,572,551 )
    Preferred stock dividends         (369,862 )        
    Preferred stock accretion         166,881         166,881  
   
 
 
 
 
  Net income (loss) available to common shareholders—basic and diluted   $ 608,584   $ (1,634,009 ) $ 918,131   $ (1,739,432 )
   
 
 
 
 
Weighted average shares outstanding:                          
  Weighted average shares outstanding—basic     56,180,338     38,753,416     56,105,338     38,752,960  
  Effect of dilutive securities:                          
    Stock options     179,981         311,742      
    Convertible preferred stock                  
   
 
 
 
 
Weighted average shares outstanding—diluted     56,360,319     38,753,416     56,417,080     38,752,960  
   
 
 
 
 

        For the three and six months ended June 30, 2002, potential common shares from the stock options were anti-dilutive and excluded from the calculation of diluted earnings per share because the exercise price was greater than the average market price of the common shares. The number of shares excluded for stock options were 485,787 and 248,129 for the three and six months June 30, 2002, respectively.

        For the three and six months ended June 30, 2001, potential common shares from the stock options and convertible preferred stock were anti-dilutive and excluded from the calculation of diluted earnings (loss) per share. The number of common shares excluded for stock options were 335,306 and 289,173 for the three and six months ended June 30, 2001, respectively. The number of common shares excluded for convertible preferred stock were 5,625,000 and 5,156,250, for the three and six months ended June 30, 2001, respectively.

        For the three and six months ended June 30, 2001, net loss available to common shareholders—diluted was equal to net loss available to common shareholders—basic because of the anti-dilutive effect of the preferred stock accretion.

10



8. Comprehensive Income (Loss)

        Comprehensive income (loss) for the three and six months ended June 30, 2002 and 2001 was as follows:

 
  Three Months Ended
June 30,

  Six Months Ended
June 30,

 
 
  2002
  2001
  2002
  2001
 
Net income (loss)   $ 608,584   $ (1,836,990 ) $ 918,131   $ (1,572,551 )
Other comprehensive income (loss):                          
  Transition adjustment relating to the adoption of SFAS No. 133, net of taxes